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Núcleo Hector Ochoa Zuleta, Tarabana 3023, Lara, Venezuela
Correspondence should be addressed to José Emilio Mesonero; mesonero@unizar.es
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Oxidative stress is thought to play a key role in the development of intestinal damage in intestinal inflammatory diseases. Several
molecules are involved in the intestinal inflammation, either as pro- or anti-inflammatory factors; however, their effects on intestinal
oxidative stress seem to be controversial. This work analyzes the contribution of pro- and anti-inflammatory molecules to the
balance of oxidative damage in intestinal epithelial cells, as well as their effects on cellular antioxidant enzyme activity. With this
purpose, the lipid and protein oxidation, together with the activity of catalase, superoxide dismutase, and glutathione peroxidase,
were determined in the Caco-2 cells treated with serotonin, adenosine, melatonin, and TNF𝛼, as proinflammatory factors, and
IL-10, as an anti-inflammatory cytokine. The results have shown that all the proinflammatory factors assayed increased oxidative
damage. In addition, these factors also inhibited the activity of antioxidant enzymes in the cells, except melatonin. In contrast,
IL-10 did not alter these parameters but was able to reduce the prooxidant effects yielded by serotonin, adenosine, melatonin, or
TNF𝛼, in part by restoring the antioxidant enzymes activities. In summary, proinflammatory factors may induce oxidative damage
in intestinal epithelial cells, whereas IL-10 seems to be able to restore the altered redox equilibrium in Caco-2 cells.
1. Introduction
Intestinal inflammation is an adaptive response that is
triggered by adverse conditions such as tissue injury and
infection. Moreover, intestinal inflammation alters the effi-
ciency and the whole physiology of the intestinal tract. The
integrity of the epithelial barrier is essential for preventing
the development of inflammatory conditions in the intestine;
in fact, it is well known that the structure and the function
of intestinal barrier are compromised in inflammatory bowel
diseases (IBDs). The specific pathways leading to cellular
damage in chronic intestinal inflammation are not completely
understood; however, oxidative stress is a potential triggering
factor for IBDs [1]. In this context, several proinflammatory
mediators may generate further oxidation products, lead-
ing to a self-sustaining and autoamplifying vicious circle
that eventually impairs the gut barrier thus aggravating
inflammatory damage [2]. This kind of process has been also
described in the cardiovascular system [3].
Several gastrointestinal (GI) molecules that modulate GI
activity [4–6] have also been noted as being involved in
intestinal inflammation. Thus, some of these molecules at
high concentrationsmay act as proinflammatory factors.This
is the case for serotonin (5-HT) [7, 8], adenosine [9, 10], and
TNF𝛼 [11], whereas others, such as melatonin, may act either
as a proinflammatory factor at high concentrations or as an
anti-inflammatorymolecule depending on the cell conditions
[12]. Moreover, interleukin-10 (IL-10), a well-known anti-
inflammatory cytokine [13–15], has also been shown to
modulate intestinal physiology [16].
In the last decade, the incidence of intestinal inflamma-
tory diseases has been growing, and there is an increasing
interest in understanding the mechanisms by which physi-
ological GI molecules, present in the intestinal mucosa, may
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contribute to intestinal inflammation by affecting intestinal
epithelium. Thus, the aim of the present work has been the
analysis of the effect of 5-HT, adenosine, melatonin, and
TNF𝛼, acting as proinflammatory factors, and IL-10, acting
as an anti-inflammatory cytokine, in the intestinal epithelial
cells’ redox equilibrium.
2. Materials and Methods
2.1. Reagents. The following drugs and substances were
used (abbreviations and suppliers in parentheses): serotonin
(5-HT), melatonin, adenosine, glutathione reductase, L-
glutathione reduced, 𝛽-nicotinamide adenine dinucleotide
phosphate (NADPH), tert-butyl hydroperoxide, 1-methyl-
2-phenylindole, acetonitrile, methane sulfonic acid, 1,1,3,3-
tetramethoxypropane, 2,4-dinitrophenylhydrazine (DNPH),
trichloroacetic acid, guanidine, xanthine, xanthine oxidase
(Sigma-Aldrich, St. Louis, MO, USA), TNF𝛼, and IL-10
(Peprotech, Rocky Hill, NJ, USA). All generic reagents were
purchased from Sigma-Aldrich and Roche Applied Sciences
(Sant Cugat del Vallés, Barcelona, Spain).
2.2. Cell Culture and Cell Homogenate Preparation. Caco-
2/TC7 cells have been used in the present study since they are
an excellent human enterocyte-like model to study intestinal
epithelial physiology [17, 18]. The cells were always used
between passages 19 and 35 and were cultured at 37∘C in
an atmosphere of 5% CO
2
and maintained in high-glucose
DMEM supplemented with 2mM glutamine, 100U/mL
penicillin, 100 𝜇g/mL streptomycin, 1% nonessential amino
acids, and 20% heat-inactivated fetal bovine serum (FBS)
(Life Technologies, Carlsbad, CA). The cells were passaged
enzymatically (0.25% trypsin-1mM EDTA), subcultured in
25 cm2 plastic culture flasks (Sarstedt, Nuembrecht, Ger-
many), and seeded at a density of 104 cells/cm2. The medium
was changed 48 h after seeding and daily thereafter. The
experiments were carried out in the cells 14 days after seeding
(nine days after confluence), and the cell medium was FBS-
free for 24 h before using the cells. Cell activity through
different passages and after a postconfluence condition has
been shown to be normal [18]. For the experiments, cells
were seeded in 6-well plates at a density of 2 × 105 cells/
well. Two wells per condition (treatment) were used in
each independent experiment, which corresponded to a
different passage of Caco-2/TC7 cells. The measurement of
the different parameters was performed in triplicate for each
well cell culture condition. Serotonin 100 𝜇M, adenosine
100 𝜇M,melatonin 5mM,TNF𝛼 5 ng/mL, and/or IL-10 at two
concentrations (0.01 and 25 ng/mL) were added to the cell
medium for one day before the measurement of oxidative
parameters. Cell status under the treatments was assessed by
both microscopy and cell count, and none of the treatments
appeared to affect cell culture morphology, cell proliferation,
or cell viability (data not shown).
For cell homogenate preparation, the cells were resus-
pended and homogenized with a cold Tris-manitol buffer
(Tris 2mM,mannitol 50mM, pH 7.1, protease inhibitors, and
0.02% sodium azide). Then, the homogenate was disrupted
by sonication (15 1-s bursts, 60W). Antioxidant enzymes’
activity was measured in the cellular homogenate. For lipid
peroxidation and protein carbonyl analysis, the homogenate
was additionally centrifuged for 10min at 3,000 g, and the
supernatantwas taken for the study. Protein contentwasmea-
sured by following the Bradford method (Bio-Rad, Hercules,
CA, USA).
2.3. Measurement of Lipid and Protein Peroxidation. The
level of lipid peroxidation was determined by measur-
ing the concentration of malondialdehyde (MDA) and 4-
hydroxyalkenals (4-HDA), as described previously [19].
Briefly, MDA+4-HDA reacted with N-methyl-2-phenyl-
indole and yielded a stable chromophore that was measured
in a spectrophotometer at 586 nm, using 1,1,3,3-tetrameth-
oxypropane as standard. The results were calculated in
nmol MDA+4-HDA/mg protein and were expressed as the
percentage of the control value (100%).
Protein oxidation was analyzed by carbonyl level mea-
surement as previously described [19]. Cell homogenates
were incubated with the classical carbonyl reagent DNPH,
and protein carbonylation was measured spectrophotometri-
cally at 375 nm.The results were calculated in nmol carbonyl
groups/mg protein and were expressed as percentage of the
control value (100%).
2.4. Analysis of Antioxidant Enzymes’ Activity. The activ-
ity of the antioxidant enzymes catalase (CAT), superoxide
dismutase (SOD), and glutathione peroxidase (GPx) was
measured by adding specific substrates and measuring the
rates of disappearance of the substrates, following protocols
previously described [19]. CAT activity was calculated as




in nmol/mg protein × min that was
measured spectrophotometrically at 240 nm.
In relation to SOD, the cytosolic superoxide dismutase
CuZnSOD form was analyzed. SOD activity was measured
by the production of superoxide radicals that was determined
with a xanthine/xanthine-oxidase system, which induces a
cytochrome C reduction. This reduction was measured at
550 nm and SOD activity calculated as U/mg prot ×min.
The GPx analyzed in our study was the GPx2 form
(GPx-GI), which is cytoplasmatic and the most abundantly
expressed in GI tract and liver. GPx activity was measured
in a cell homogenate mixed with potassium phosphate, pH
7.0, containing 10mM glutathione, 0.25 units of glutathione
reductase, and 1.5mM 𝛽-NADPH. The decrease in NADPH
during oxidation of NADPH to NADP is indicative of
GPx activity, which was measured spectrophotometrically at
340 nm and calculated as NADPH nmol/mg prot ×min. The
results were expressed as percentages of CAT, SOD, and GPx
activities of control value (100%).
2.5. Statistical Analysis. All results are expressed as means
± the standard error of the mean (SE) of five indepen-
dent experiments. Statistical comparisons were performed
using one-way ANOVA followed by the Bonferroni post-
test with a confidence interval of 95% (𝑃 < 0.05). Normal




















































































































































































Figure 1: Effect of 5-HT, adenosine, melatonin, TNF𝛼, and/or IL-10 on lipid peroxidation (a) and protein oxidation (b). Caco-2 cells were
treated throughout the course of one day with either 5-HT 100 𝜇M, adenosine (Ado) 100 𝜇M, melatonin (Mel) 5mM, TNF𝛼 5 ng/mL, or
IL-10 at two concentrations, 0.01 or 25 ng/mL. Results were expressed as the percentages of the control value (100%) and were indicated as
the mean ± SE of five independent experiments. ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001, compared with control (C); #𝑃 < 0.05, ##𝑃 < 0.01, and
###
𝑃 < 0.001 compared with the corresponding condition of treatment without IL-10.
distribution was previously confirmed with the D’Agostino-
Pearson test. Statistical analysis was carried out using the
computer-assisted Prism GraphPad Program (Prism version
4.0, GraphPad Software, San Diego, CA).
3. Results
3.1. Effect of 5-HT, Adenosine, Melatonin, TNF𝛼, and IL-10 on
Lipid and Protein Oxidation in Caco-2 Cells. The results show
that Caco-2 cells treated with 5-HT, adenosine, melatonin, or
TNF𝛼 significantly increased lipid peroxidation (Figure 1(a))
and protein carbonyl (Figure 1(b)) levels. Conversely, IL-10
did not appear to modify the cell oxidative status. However,
IL-10, at the two concentrations assayed, was able to reduced
lipid and protein oxidation induced by 5-HT, melatonin and
TNF𝛼. Oxidative damage in lipids and proteins yielded by
adenosine was only reverted by IL-10 at high concentration
(25 ng/mL) (Figure 1).
3.2. Analysis of the Activity of Antioxidant Enzymes CAT,
SOD and GPx in Caco-2 Cells Treated with 5-HT, Adenosine,
Melatonin, TNF𝛼 and IL-10. The results have shown that 5-
HT, adenosine, and TNF𝛼 significantly reduced CAT activity,
which did not seem to be significantly affected by melatonin
or IL-10 at the two concentrations assayed. In combined
treatments, IL-10 at a low concentration (0.01 ng/mL) seemed
to reverse CAT inhibition yielded by TNF𝛼 and, on the
contrary, it showed to increase the inhibition of CAT activity
induced by 5-HT, adenosine, or melatonin. However, IL-
10 at a high concentration (25 ng/mL) was able to reverse
CAT inhibition induced by 5-HT and adenosine and to
increase significantly CAT activity in presence of melatonin
(Figure 2(a)).
In relation with SOD, 5-HT showed to reduce its activity,
and this effect was not only reversed by IL-10 at a high
concentration but even surpassed it (Figure 2(b)). Adeno-
sine, melatonin, TNF𝛼, and IL-10 at the two concentrations
assayed did not seem to affect SOD activity. Surprisingly,
treatment with IL-10 at a high concentration plus melatonin
yielded a significant increase of SOD activity (Figure 2(b)).
The analysis of GPx showed that only adenosine sig-
nificantly reduced GPx activity and that this effect was
also reversed by IL-10 at a high concentration (Figure 2(c)).
Curiously, the treatment withmelatonin, which alone did not
affectGPx activity, togetherwith IL-10 at a high concentration
showed an increase in antioxidant GPx activity above the
control (Figure 2(c)).
4. Discussion and Conclusions
The results obtained in this work demonstrate that the intesti-
nal proinflammatory treatments analyzed—5-HT, adeno-
sine, TNF𝛼, and melatonin at high concentrations—induced
oxidative effects in lipids and proteins of intestinal epithelial
cells. This oxidative damage did not seem to significantly
affect the survival of the cells; however, it may be added
to the prooxidant status settled in the intestinal cells under
inflammatory conditions. The prooxidant effects of these
molecules have also been noted in different tissues [11, 20, 21].
In contrast, the anti-inflammatory cytokine IL-10, which did
not appear to affect lipid and protein oxidation at any concen-
tration assayed, was shown to reverse the oxidative damage
in lipids and proteins induced by the proinflammatory
molecules tested, except IL-10 a low concentration, which did
not significantly reduce the lipid peroxidation and protein
carbonyl levels yielded by adenosine. These results suggest
that IL-10 effects may be evident in tissues that have been
exposed to inflammatory conditions, as a previous study has
concluded [22].
Antioxidant enzyme activity is the main way to restore
redox equilibrium in cells, and intestinal inflammation has

























































































































































































Figure 2: Effect of 5-HT, adenosine, melatonin, TNF𝛼, and/or IL-10 on CAT (a), SOD (b), and GPx (c) activity. Caco-2 cells were treated
throughout the course of one day with 5-HT 100 𝜇M, adenosine (Ado) 100 𝜇M, melatonin (Mel) 5mM, TNF𝛼 5 ng/mL, or IL-10 at two
concentrations, 0.01 or 25 ng/mL. Results were expressed as percentages of the enzyme activity of control cells (100%) and were indicated
as the mean ± SE of five independent experiments. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001, compared with control (C); #𝑃 < 0.05, and
###
𝑃 < 0.001 compared with the corresponding condition of treatment without IL-10.
been characterized by marked but differing alterations of
various enzymes involved in oxidant/antioxidant intestinal
epithelium homeostasis. In terms of intestinal inflammatory
diseases, SOD [23, 24] and CAT activities [25, 26] have
been observed to be altered in the intestinal mucosa of IBD;
however, the results of GPx activity have been shown to be
more controversial [27, 28]. In this context, CAT, SOD, and
GPx activities were measured in order to analyze whether
they were involved in both the oxidative effects yielded
by proinflammatory molecules and the cell oxidative equilib-
rium restoration carried out by IL-10.
The proinflammatory factors tested have been shown to
significantly reduce the activity of some of the antioxidant
enzymes, even though this effect did not appear to be the only
responsible for their observed prooxidant action on lipids and
proteins. Thus, our results suggest that the oxidative effect of
5-HT in Caco-2 cells may be in part due to the inhibition
of CAT and SOD activity. In agreement with these results, a
previous study made in cardiac myocytes has demonstrated




[29]. In the case
of adenosine, it has been shown to reduce CAT and GPx
activity, which may contribute to its effect on the oxidative
damage of lipids and proteins. Adenosine effects on antiox-
idant enzymes have not been deeply analyzed; despite this,
the activity of adenosine deaminase and its negative corre-
lation with CAT, SOD, and GPx activities has been demon-
strated in plasma and blood cells [30]. In relation to TNF𝛼,
its prooxidant effect might be in part mediated by the
inhibition of CAT activity, as it has been recently described in
osteoblasts [31]. Finally, in contrast, melatonin did not appear
to affect any enzyme activity measured, and consequently,
these antioxidant enzymes did not seem to be involved in the
strong oxidative stress yielded by melatonin in proteins and
lipids. Melatonin is considered an antioxidant molecule, but
it may also act as a prooxidant factor. In fact, melatonin has
been shown to generate reactive oxygen species [12]. More-
over, and in agreement with our results, it has been previously
suggested that melatonin may induce an indirect prooxidant
effect that contributes to acute inflammation [32].
In relation to IL-10, this cytokine alone did not appear
to alter the antioxidant enzymes activities analyzed at any
of the two concentrations assayed, which may explain its
lack of effect on lipid and protein oxidation in Caco-2 cells.
In contrast, under co-treatment with the proinflammatory
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mediators IL-10 at a high concentration was shown to reverse
their inhibitory effect on the different antioxidant enzymes
activities. Thus, IL-10 at a high concentration reversed CAT
and SOD inhibition induced by 5-HT, and CAT and GPx
inhibition yielded by adenosine. In contrast, IL-10 at a low
concentration did not seem to reverse any effect on SOD and
GPx activity inhibition, but surprisingly it seemed to restore
CATactivity inhibited byTNF𝛼 treatment. In agreementwith
these results, recent studies have demonstrated the ability




production induced by IFN-𝛾 and
TNF𝛼-activated macrophages [33]. Surprisingly, IL-10 at low
concentration seemed to aggravate CAT activity inhibition
induced by 5-HT, adenosine, and melatonin.
From our results, it can be inferred that IL-10 effects
depend on its concentration, as it has been recently described
in Caco-2 cells [16], and in cardiovascular events [34].
The protective effect of IL-10 against the oxidative damage
induced by prooxidantmolecules has also been demonstrated
in cardiomyocytes [35]. Recent results in endothelium have
suggested that the antioxidant effect of IL-10 under proin-
flammatory conditions may be explained by the activation of
PI3k signaling [36]. Since this intracellular pathway has also
been recently described inCaco-2 cells [16] as triggered by IL-
10, it may be inferred that PI3k pathway might also mediate
IL-10 antioxidant effects in intestinal epithelial cells.
Interestingly, CAT, SOD, and GPx activities, which
remained unaltered under treatment with either melatonin
or with IL-10 at high concentrations, were significantly aug-
mented by the cotreatment of the cells with both molecules,
thus suggesting a synergistic antioxidant action of both fac-
tors. Our results agree with previous studies that concluded
that melatonin may exert a beneficial effect in the inflamma-
tory processes by stimulating IL-10 production (reviewed in
[37, 38]).
In brief, our study demonstrates that GI molecules
involved in intestinal inflammation may also act as prooxi-
dant factors in intestinal epithelial cells.This effectmay be due
in part to the inhibition of the activity of antioxidant enzymes.
This prooxidant effect might contribute to a worsening of
inflammation by damaging the intestinal epithelium. In addi-
tion, IL-10, mainly at high concentrations, may reverse the
prooxidative effects induced by the proinflammatory factors,
thus suggesting that IL-10may contribute to the improvement
of the inflammation not only through anti-inflammatory but
also through antioxidant effects. This antioxidant effect of
IL-10 in the intestinal epithelium reinforces the role of this
cytokine as a successful therapy to treat intestinal inflamma-
tion and IBDs.
The results of the current study may be useful for
clarifying the processes involved in intestinal inflammation
and may contribute to the design of specific therapies in the
treatment of intestinal inflammatory diseases by acting on the
redox balance.
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